Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Irwin Chaiken

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Vitamins and Hormones|August 23, 2005
Cytokine recognition by human interleukin 5 receptorTetsuya Ishino, Noreen Robertson, Irwin Chaiken
Molecules (Basel, Switzerland)|August 21, 2013
Click chemistry in peptide-based drug designHuiyuan Li, Rachna Aneja, Irwin Chaiken
The Journal of Biological Chemistry|December 10, 2003
Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognitionTetsuya Ishino, Gianfranco Pasut, Jeffery Scibek, et al.
Journal of Molecular Recognition : JMR|May 12, 2004
Proteins, recognition networks and developing interfaces for macromolecular biosensingMauro Sergi, John Zurawski, Simon Cocklin, et al.
Current Pharmaceutical Design|May 14, 2008
Structure-based rationale for interleukin 5 receptor antagonismTetsuya Ishino, Adrian E Harrington, Hosahudya Gopi, et al.
Frontiers in Immunology|March 26, 2021
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 PandemicPriyanka Shah, Gabriela A Canziani, Erik P Carter, et al.
The Journal of Biological Chemistry|April 14, 2005
Receptor epitope usage by an interleukin-5 mimetic peptideTetsuya Ishino, Cecilia Urbina, Madhushree Bhattacharya, et al.
Journal of Virology|September 8, 2006
Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralizationXinzhen Yang, Inna Lipchina, Simon Cocklin, et al.
Proteins|April 11, 2018
Roles of conserved tryptophans in trimerization of HIV-1 membrane-proximal external regions: Implications for virucidal design via alchemical free-energy molecular simulationsSteven T Gossert, Bibek Parajuli, Irwin Chaiken, et al.
Protein Science : a Publication of the Protein Society|September 14, 2020
Roles of variable linker length in dual acting virucidal entry inhibitors on HIV-1 potency via on-the-fly free energy molecular simulationsSteven T Gossert, Bibek Parajuli, Irwin Chaiken, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Vitamins and Hormones|August 23, 2005
Cytokine recognition by human interleukin 5 receptorTetsuya Ishino, Noreen Robertson, Irwin Chaiken
Molecules (Basel, Switzerland)|August 21, 2013
Click chemistry in peptide-based drug designHuiyuan Li, Rachna Aneja, Irwin Chaiken
The Journal of Biological Chemistry|December 10, 2003
Kinetic interaction analysis of human interleukin 5 receptor alpha mutants reveals a unique binding topology and charge distribution for cytokine recognitionTetsuya Ishino, Gianfranco Pasut, Jeffery Scibek, et al.
Journal of Molecular Recognition : JMR|May 12, 2004
Proteins, recognition networks and developing interfaces for macromolecular biosensingMauro Sergi, John Zurawski, Simon Cocklin, et al.
Current Pharmaceutical Design|May 14, 2008
Structure-based rationale for interleukin 5 receptor antagonismTetsuya Ishino, Adrian E Harrington, Hosahudya Gopi, et al.
Frontiers in Immunology|March 26, 2021
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 PandemicPriyanka Shah, Gabriela A Canziani, Erik P Carter, et al.
The Journal of Biological Chemistry|April 14, 2005
Receptor epitope usage by an interleukin-5 mimetic peptideTetsuya Ishino, Cecilia Urbina, Madhushree Bhattacharya, et al.
Journal of Virology|September 8, 2006
Antibody binding is a dominant determinant of the efficiency of human immunodeficiency virus type 1 neutralizationXinzhen Yang, Inna Lipchina, Simon Cocklin, et al.
Proteins|April 11, 2018
Roles of conserved tryptophans in trimerization of HIV-1 membrane-proximal external regions: Implications for virucidal design via alchemical free-energy molecular simulationsSteven T Gossert, Bibek Parajuli, Irwin Chaiken, et al.
Protein Science : a Publication of the Protein Society|September 14, 2020
Roles of variable linker length in dual acting virucidal entry inhibitors on HIV-1 potency via on-the-fly free energy molecular simulationsSteven T Gossert, Bibek Parajuli, Irwin Chaiken, et al.
Pageof 6